Cargando…

Lassa Fever Virus Binds Matriglycan—A Polymer of Alternating Xylose and Glucuronate—On α-Dystroglycan

Lassa fever virus (LASV) can cause life-threatening hemorrhagic fevers for which there are currently no vaccines or targeted treatments. The late Prof. Stefan Kunz, along with others, showed that the high-affinity host receptor for LASV, and other Old World and clade-C New World mammarenaviruses, is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Joseph, Soumya, Campbell, Kevin P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473316/ https://www.ncbi.nlm.nih.gov/pubmed/34578260 http://dx.doi.org/10.3390/v13091679

Ejemplares similares

Identification of Matriglycan by Dual Exoglycosidase Digestion of α-Dystroglycan
por: Chandel, Ishita, et al.
Publicado: (2023)

N-terminal domain on dystroglycan enables LARGE1 to extend matriglycan on α-dystroglycan and prevents muscular dystrophy
por: Okuma, Hidehiko, et al.
Publicado: (2023)

Matriglycan: a novel polysaccharide that links dystroglycan to the basement membrane
por: Yoshida-Moriguchi, Takako, et al.
Publicado: (2015)

Exogenous expression of the glycosyltransferase LARGE1 restores α-dystroglycan matriglycan and laminin binding in rhabdomyosarcoma
por: Beltrán, Daniel, et al.
Publicado: (2019)

POMK regulates dystroglycan function via LARGE1-mediated elongation of matriglycan
por: Walimbe, Ameya S, et al.
Publicado: (2020)

Cell surface glycan engineering reveals that matriglycan alone can recapitulate dystroglycan binding and function
por: Sheikh, M. Osman, et al.
Publicado: (2022)

Involvement of abnormal dystroglycan expression and matriglycan levels in cancer pathogenesis
por: Quereda, Cristina, et al.
Publicado: (2022)

The functional O-mannose glycan on α-dystroglycan contains a phospho-ribitol primed for matriglycan addition
por: Praissman, Jeremy L, et al.
Publicado: (2016)

Ribitol enhances matriglycan of α-dystroglycan in breast cancer cells without affecting cell growth
por: Lu, Pei J., et al.
Publicado: (2020)

Dynamic Dystroglycan Complexes Mediate Cell Entry of Lassa Virus
por: Herrador, Antonio, et al.
Publicado: (2019)

Target specificity of selective bioactive compounds in blocking α-dystroglycan receptor to suppress Lassa virus infection: an in silico approach
por: Arefin, Adittya, et al.
Publicado: (2021)

Loss of α-Dystroglycan Laminin Binding in Epithelium-derived Cancers Is Caused by Silencing of LARGE
por: de Bernabé, Daniel Beltrán-Valero, et al.
Publicado: (2009)

Structural basis of laminin binding to the LARGE glycans on dystroglycan
por: Briggs, David C., et al.
Publicado: (2016)

Pathogenesis of Lassa Fever
por: Yun, Nadezhda E., et al.
Publicado: (2012)

Structural basis for matriglycan synthesis by the LARGE1 dual glycosyltransferase
por: Katz, Michael, et al.
Publicado: (2022)

Dystroglycan Binding to α-Neurexin Competes with Neurexophilin-1 and Neuroligin in the Brain
por: Reissner, Carsten, et al.
Publicado: (2014)

Molecular analysis of the interaction of LCMV with its cellular receptor α-dystroglycan
por: Kunz, Stefan, et al.
Publicado: (2001)

Structural flexibility of human α‐dystroglycan
por: Covaceuszach, Sonia, et al.
Publicado: (2017)

Humoral and cellular immune responses to Lassa fever virus in Lassa fever survivors and their exposed contacts in Southern Nigeria
por: Ugwu, Chinedu, et al.
Publicado: (2022)

Imported lassa fever in Germany: molecular characterization of a new lassa virus strain.
por: Günther, S, et al.
Publicado: (2000)

On the Front Lines of Lassa Fever
por: Bausch, Daniel G., et al.
Publicado: (2004)

Animal Models of Lassa Fever
por: Sattler, Rachel A., et al.
Publicado: (2020)

Lassa fever — the road ahead
por: Garry, Robert F.
Publicado: (2022)

High degree of conservation of the enzymes synthesizing the laminin-binding glycoepitope of α-dystroglycan
por: Bigotti, Maria Giulia, et al.
Publicado: (2021)

Imported Lassa Fever, Pennsylvania, USA, 2010
por: Amorosa, Valerianna, et al.
Publicado: (2010)

Xylosyl- and glucuronyltransferase functions of LARGE in α-dystroglycan modification are conserved in LARGE2
por: Inamori, Kei-ichiro, et al.
Publicado: (2013)

Molecular confirmation of Lassa fever imported into Ghana
por: Bonney, Joseph H.K., et al.
Publicado: (2016)

Protective role for the N-terminal domain of α-dystroglycan in Influenza A virus proliferation
por: de Greef, Jessica C., et al.
Publicado: (2019)

The conserved WW-domain binding sites in Dystroglycan C-terminus are essential but partially redundant for Dystroglycan function
por: Yatsenko, AS, et al.
Publicado: (2009)

Pathogenesis of lassa fever in cynomolgus macaques
por: Hensley, Lisa E, et al.
Publicado: (2011)

T Cell-Dependence of Lassa Fever Pathogenesis
por: Flatz, Lukas, et al.
Publicado: (2010)

Lassa Fever, Nigeria, 2003 and 2004
por: Omilabu, Sunday Aremu, et al.
Publicado: (2005)

Ribavirin for Lassa Fever Postexposure Prophylaxis
por: Hadi, Christiane M., et al.
Publicado: (2010)

Lassa Fever, Nigeria, 2005–2008
por: Ehichioya, Deborah U., et al.
Publicado: (2010)

Laboratory Diagnosis of Lassa Fever, Liberia
por: Panning, Marcus, et al.
Publicado: (2010)

Advanced Vaccine Candidates for Lassa Fever
por: Lukashevich, Igor S.
Publicado: (2012)

Vaccine platforms for the prevention of Lassa fever
por: Purushotham, Jyothi, et al.
Publicado: (2019)

Lassa fever and global health security
por: The Lancet Infectious Diseases
Publicado: (2018)

PROSPECTS OF LASSA FEVER CANDIDATE VACCINES
por: Isaac, Ademusire Babatunde, et al.
Publicado: (2022)

Lassa and Crimean-Congo Hemorrhagic Fever Viruses, Mali
por: Baumann, Jan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bnuffidko83jlkau0u1loosu5o